Cohort study of plasma natriuretic peptides for identifying left ventricular systolic dysfunction in primary care
- 22 August 1998
- Vol. 317 (7157) , 516-519
- https://doi.org/10.1136/bmj.317.7157.516
Abstract
Objectives : To determine whether blood natriuretic peptide concentrations are helpful in identifying or excluding left ventricular systolic dysfunction in stable survivors of acute myocardial infarction. Design : Comparison of blood natriuretic peptide concentrations with echocardiographic assessment of left ventricular systolic function in a general practice population. Setting : Practices in Western District of Glasgow audit group. Subjects : 134 long term survivors of myocardial infarction recalled for echocardiography as part of a primary care secondary prevention audit. Main outcome measures : Area under the receiver operating curve for brain natriuretic peptide and N-terminal atrial natriuretic peptide. Results : Brain natriuretic peptide was of some diagnostic utility in identifying the minority of subjects with severe left ventricular dysfunction (area under curve=0.73) but was unable to discriminate between patients with moderately severe dysfunction and those with preserved left ventricular function (area under curve for moderate or severe dysfunction=0.54). The corresponding values forN-terminal atrial natriuretic peptide for severe and moderate or severe dysfunction were 0.55 and 0.56 respectively. Conclusions : Blood natriuretic peptide concentrations are not useful in identifying important left ventricular systolic dysfunction in stable survivors of myocardial infarction.Keywords
This publication has 27 references indexed in Scilit:
- Biochemical detection of left-ventricular systolic dysfunctionThe Lancet, 1998
- Digitalis increases brain natriuretic peptide in patients with severe congestive heart failureAmerican Heart Journal, 1997
- Superiority of Brain Natriuretic Peptide as a Hormonal Marker of Ventricular Systolic and Diastolic Dysfunction and Ventricular HypertrophyHypertension, 1996
- Plasma cardiac natriuretic peptide determination as a screening test for the detection of patients with mild left ventricular impairment.Heart, 1996
- Natriuretic peptides and cyclic guanosine 3',5'-monophosphate in asymptomatic and symptomatic left ventricular dysfunction.Heart, 1996
- Comparison of atrial natriuretic peptide, B-type natriuretic peptide, and N-terminal proatrial natriuretic peptide as indicators of left ventricular systolic dysfunctionThe American Journal of Cardiology, 1996
- Effect of low dose beta blockers on atrial and ventricular (B type) natriuretic factor in heart failure: a double blind, randomised comparison of metoprolol and a third generation vasodilating beta blocker.Heart, 1995
- The utility of clinical, electrocardiographic, and roentgenographic variables in the prediction of left ventricular functionThe American Journal of Cardiology, 1995
- Detection of left ventricular dysfunction after acute myocardial infarction: comparison of clinical, echocardiographic, and neurohormonal methods.Heart, 1994
- Increased plasma levels of brain natriuretic peptide in patients with isolated diastolic dysfunctionAmerican Heart Journal, 1994